Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an...

nork Duska, Linda R., Java, James J., Cohn, David E., Burger, Robert A.
Argitaratua izan da Gynecol Oncol (2015)

Pathologic and Treatment Outcomes Among a Geriatric Population of Endometrial Cancer Patients: An NRG Oncology/Gynecologic Oncology Group Ancillary Data Analysis of LAP2

nork Bishop, Erin A., Java, James J., Moore, Kathleen N., Walker, Joan L.
Argitaratua izan da Int J Gynecol Cancer (2017)

Mixed-methods content and sentiment analysis of adolescents’ voice-diaries describing daily experiences with asthma and self-management decision-making

nork Mammen, Jennifer R., Java, James J., Rhee, Hyekyun, Butz, Arlene M., Halterman, Jill S., Arcoleo, Kimberly
Argitaratua izan da Clin Exp Allergy (2018)

Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in Gynecologic Oncology Group trials of cisplatin-base...

nork Rose, Peter G, Java, James J, Whitney, Charles W., Stehman, Frederick B, Lanciano, Rachelle, Thomas, Gillian M
Argitaratua izan da Gynecol Oncol (2014)

The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients – An analysis of NRG Oncology/Gynecologic Oncology Group tr...

nork Chan, John K., Java, James J., Fuh, Katherine, Monk, Bradley J., Kapp, Daniel S., Herzog, Thomas, Bell, Jeffrey, Young, Robert
Argitaratua izan da Gynecol Oncol (2016)

Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

nork Tewari, Devansu, Java, James J., Salani, Ritu, Armstrong, Deborah K., Markman, Maurie, Herzog, Thomas, Monk, Bradley J., Chan, John K.
Argitaratua izan da J Clin Oncol (2015)

Disease Extent at Secondary Cytoreductive Surgery is Predictive of Progression-free and Overall Survival in Advanced Stage Ovarian Cancer: an NRG Oncology/Gynecologic Oncology Grou...

nork Rose, Peter G., Java, James J., Morgan, Mark A., Secord, Angeles Alvarez, Kesterson, Joshua P., Stehman, Frederick B., Warshal, David P., Creasman, William T., Hanjani, Parviz, Morris, Robert T., Copeland, Larry J.
Argitaratua izan da Gynecol Oncol (2016)

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

nork Ferriss, James S, Java, James J, Bookman, Michael A, Fleming, Gini F, Monk, Bradley J, Walker, Joan L, Homesley, Howard D, Fowler, Jeffrey, Greer, Benjamin E, Boente, Matthew P, Burger, Robert A
Argitaratua izan da Gynecol Oncol (2015)

Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study

nork Seamon, Leigh G, Java, James J, Monk, Bradley J, Penson, Richard T, Brown, Jubilee, Mannel, Robert S, Oaknin, Anna, Leitao, Mario M, Eisenhauer, Eric L, Long, Harry J, Liao, Shu Y, Tewari, Krishnansu S
Argitaratua izan da Br J Cancer (2018)

Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group...

nork Garcia-Soto, Arlene E, Java, James J, Neira, Wilberto Nieves, Pearson, J Matthew, Cohn, David E., Lele, Shashikant B, Tewari, Krishnansu S, Walker, Joan L, Secord, Angeles Alvarez, Armstrong, Deborah K, Copeland, Larry J
Argitaratua izan da Gynecol Oncol (2016)

Does Adjuvant Chemotherapy Dose Modification Have an Impact On the Outcome of Patients diagnosed with Advanced Stage Ovarian Cancer? An NRG Oncology/Gynecologic Oncology Group Stud...

nork Olawaiye, Alexander B., Java, James J., Krivak, Thomas C., Friedlander, Michael, Mutch, David G., Glaser, Gretchen, Geller, Melissa, O’Malley, David M., Wenham, Robert M., Lee, Roger B., Bodurka, Diane C., Herzog, Thomas J., Bookman, Michael A.
Argitaratua izan da Gynecol Oncol (2018)

Corrigendum to “Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Onc...

nork Olawaiye, Alexander B., Java, James J., Krivak, Thomas C., Friedlander, Michael, Mutch, David G., Glaser, Gretchen, Geller, Melissa, O'Malley, David M., Wenham, Robert M., Lee, Roger B., Bodurka, Diane C., Herzog, Thomas J., Bookman, Michael A.
Argitaratua izan da Gynecol Oncol (2018)

Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data...

nork Moore, Kathleen N., Java, James J., Slaughter, Katrina N., Rose, Peter G., Lanciano, Rachelle, DiSilvestro, Paul A., Thigpen, J. Tate, Lee, Yi-Chun, Tewari, Krishnansu S., Chino, Junzo, Seward, Shelly M., Miller, David S., Salani, Ritu, Moore, David H., Stehman, Frederick B.
Argitaratua izan da Gynecol Oncol (2016)

Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: A NRG/Gynecologic Oncology Group Study

nork Bishop, Erin A., Java, James J., Moore, Kathleen N., Spirtos, Nick M, Pearl, Michael L, Zivanovic, Oliver, Kushner, David M, Backes, Floor, Hamilton, Chad A., Geller, Melissa A., Hurteau, Jean, Mathews, Cara, Wenham, Robert M., Ramirez, Pedro T., Zweizig, Susan, Walker, Joan L.
Argitaratua izan da Am J Obstet Gynecol (2017)

Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients()

nork Fuh, Katherine C., Java, James J., Chan, John K., Kapp, Daniel S., Monk, Bradley J., Burger, Robert A., Young, Robert C., Alberts, David S., McGuire, William P., Markman, Maurie, Bell, Jeffrey, Ozols, Robert F., Armstrong, Deborah K., Aghajanian, Carol, Bookman, Michael A., Mannel, Robert S.
Argitaratua izan da Gynecol Oncol (2019)

Predictive Modeling for Determination of Microscopic Residual Disease at Primary Cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study

nork Horowitz, Neil S., Maxwell, G. Larry, Miller, Austin, Hamilton, Chad A., Rungruang, Bunja, Rodriguez, Noah, Richard, Scott D., Krivak, Thomas C., Fowler, Jeffrey M., Mutch, David G., Van Le, Linda, Lee, Roger B., Argenta, Peter, Bender, David, Tewari, Krishnansu S., Gershenson, David, Java, James J., Bookman, Michael A.
Argitaratua izan da Gynecol Oncol (2017)

Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma

nork Rose, Peter G, Java, James J, Salani, Ritu, Geller, Melissa A, Alvarez, Angeles, Tewari, Krishnansu S, Bender, David P, Mutch, David G, Friedlander, Michael L, Van Le, Linda, Method, Michael W, Hamilton, Chad A, Lee, Roger B, Wenham, Robert M, Guntupalli, Saketh R, Markman, Maurie, Muggia, Franco M, Armstrong, Deborah K, Bookman, Michael A, Burger, Robert A, Copeland, Larry J
Argitaratua izan da Obstet Gynecol (2019)